Director, HTA, Value & Evidence (HV&E), Internal Medicine Early Pipeline
This role involves leading the development and execution of evidence generation strategies to support patient access for Pfizer’s obesity and non-obesity products in early clinical development. The Director will work closely with cross-functional teams to design and conduct health economics and outcomes research (HEOR) studies, ensuring that the evidence aligns with global market access needs and regulatory requirements.